Testing services · Panels

InnovexLab UTI panel

Bacterial, atypical and yeast uropathogens identified directly from the specimen, with a reflex antibiotic-resistance gene panel. Validated for swab collection, so specimens can be collected without catheterization, including from incontinent and older residents.

General medical information for education only, not medical advice. Targets as listed on InnovexLab’s requisition forms (general requisition form). Detection of a target does not by itself establish infection or determine treatment; results are interpreted by the ordering clinician with the clinical picture and, where indicated, culture and susceptibility testing.

When to consider testing

Symptomatic patients with a suspected urinary source: dysuria, frequency, urgency, suprapubic or flank pain, or fever without another source. Asymptomatic bacteriuria should not be tested or treated outside specific situations such as pregnancy.

Interpretation

Detection does not by itself establish infection; colonization and contamination are possible, especially with catheters. Confirm susceptibility where indicated.

Diagram of the urinary tract: kidneys and ureters (upper tract, where infection is pyelonephritis), bladder (lower tract, where infection is cystitis) and urethra
The urinary tract. Schematic, InnovexLab.

Targets (36)

Select a target for its clinical summary, symptoms, resistance and treatment considerations.

Gram-negative bacteria (13)

Gram-positive bacteria (6)

Atypical bacteria (2)

Yeasts (7)

Reflex antibiotic-resistance genes (8)

Request a consultation

Sources

  1. IDSA. Complicated Urinary Tract Infections guideline.
  2. IDSA. Asymptomatic Bacteriuria guideline.
  3. IDSA. Guidance on the Treatment of Antimicrobial-Resistant Gram-Negative Infections.
  4. CDC. ESBL-producing Enterobacterales.
  5. CDC. Carbapenem-resistant Enterobacterales (CRE).

Sources accessed November 2026. Links open external sites that InnovexLab does not control.

Medical disclaimer

This page is general educational information summarized from published public-health and professional-society guidance. It is not medical advice, a diagnosis or a treatment recommendation, and reading it does not create a clinician–patient relationship with InnovexLab. Decisions about testing, diagnosis and treatment belong to the treating clinician, using the patient’s history and examination, laboratory and susceptibility results, local resistance patterns and current guidelines. Guidance changes over time; consult the original sources for the latest version. InnovexLab provides this information as is and does not warrant that it is complete or current.

Patients with questions about their health should contact their own healthcare provider. In an emergency, call 911.

Sources, image credits and editorial policy

Discuss a testing program with InnovexLab

Review the panel that fits your patients, its specimen requirements, and how results and billing work.